Calcium carbonate

Generic Medicine Info
Calcium carbonate + colecalciferol + menaquinone k7: Should be taken with food.
Colecalciferol: May be taken with or without food. Take w/ meals for better absorption. Avoid taking w/ large amount of fibre-rich food.
Hypercalcaemia resulting from myeloma, bone metastases or other malignant bone disease, sarcoidosis, primary hyperparathyroidism, vitamin D overdosage. Osteoporosis due to long term immobilisation, severe hypercalciuria, kidney stones. Severe renal failure untreated by renal dialysis.
Special Precautions
Patient with achlorhydria, hypoparathyroid disease; history of kidney stones. Renal impairment. Pregnancy and lactation. Monitoring Parameters Monitor serum and urinary Ca levels, and kidney function in long term treatment.
Adverse Reactions
Significant: Constipation, bloating, gas, hypercalcaemia. Endocrine disorders: Hypophosphataemia, milk-alkali syndrome. Gastrointestinal disorders: Abdominal pain, diarrhoea, hyperacidity (acid rebound), nausea, vomiting, xerostomia. Metabolism and nutrition disorders: Anorexia. Nervous system disorders: Headache.
Drug Interactions
Increased risk of hypercalcaemia with thiazide diuretics. May enhance the effect of cardiac glycosides (e.g. digoxin). May reduce the absorption of thyroxine, bisphosphonates, Na fluoride, antibiotics (quinolone, tetracycline), and Fe. Systemic corticosteroids may reduce Ca absorption.
CIMS Class
Antacids, Antireflux Agents & Antiulcerants / Calcium/with Vitamins / Electrolytes
ATC Classification
A12AA04 - calcium carbonate ; Belongs to the class of calcium-containing preparations. Used as dietary supplements.
A02AC01 - calcium carbonate ; Belongs to the class of calcium-containing antacids.
Disclaimer: This information is independently developed by CIMS based on calcium carbonate from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in